510(k) Report

510(k) · Cleared

Cleared

Matristem Surgery Matrix RS, PSM, PSMX, Matristem Pelvic Floor Matrix

K141084510(k) TraditionalCleared Jun 17, 2015415-day reviewClass II21 CFR 878.3300

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Acell, Inc. · FTM Mesh, Surgical

Cleared on Jun 17, 2015 as substantially equivalent to K040621 (Acell, Inc., 2004) and 2 other predicates after a 415-day review. Its family tree reaches back 8 generations to 1992. 3 later devices descend from it.

Decided
Jun 17, 2015
Review
415 days
Class
Class II
Product code
FTM
Recalls
None
Predicates
3

Its longest line of descent runs back 8 generations to K921895 (1992). 35 ancestors in all, the oldest K830889 (1983). 3 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2004: 1 other ancestor2002: 1 other ancestor2000: 5 other ancestors2001: 1 other ancestor1998: 5 other ancestors1997: 3 other ancestors1996: 3 other ancestors1983: 1 other ancestor1992: 1 other ancestor1991: 3 other ancestors1993: 1 other ancestor1988: 1 other ancestor1985: 1 other ancestor2016: 1 descendant cleared2019: 1 descendant cleared2017: 1 descendant clearedK921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K980431 · Surgisis · Cook Biotech, Inc. · 1998K992159 · Surgisis Sling · Cook Biotech, Inc. · 1999K001738 · Depuy Restore Orthobiologic Soft Tissue Implant · DePuy Orthopaedics, Inc. · 2000K021637 · Acell Ubm Lyophilized Wound Dressing · Acell, Inc. · 2002×2: 2 generations cleared close together, K040621 (2004), K041140 (2004) 19801990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 2 other ancestors3 generations back: 12 other ancestors4 generations back: 7 other ancestors5 generations back: 5 other ancestors 1 generation forward: 1 descendant2 generations forward: 2 descendants K041140 · Acell Ubm Surgical Mesh ML and Mlplus · Acell, Inc. · 2004K040621 · Acell Ubm Surgical Mesh · Acell, Inc. · 2004K021637 · Acell Ubm Lyophilized Wound Dressing · Acell, Inc. · 2002K001738 · Depuy Restore Orthobiologic Soft Tissue Implant · DePuy Orthopaedics, Inc. · 2000K992159 · Surgisis Sling · Cook Biotech, Inc. · 1999K980431 · Surgisis · Cook Biotech, Inc. · 1998K961810 · Supple Peri-Guard Pericardium · Bio-Vascular, Inc. · 1996K921895 · Tissue Patch, Tissue Graft · Bio-Vascular, Inc. · 1992−50
  1. Root · 8 generations backK921895 Tissue Patch, Tissue GraftBio-Vascular, Inc. · 1992
  2. 7 generations backK961810 Supple Peri-Guard PericardiumBio-Vascular, Inc. · 1996
  3. 6 generations backK980431 SurgisisCook Biotech, Inc. · 1998
  4. 5 generations backK992159 Surgisis SlingCook Biotech, Inc. · 1999
  5. 4 generations backK001738 Depuy Restore Orthobiologic Soft Tissue ImplantDePuy Orthopaedics, Inc. · 2000
  6. 3 generations backK021637 Acell Ubm Lyophilized Wound DressingAcell, Inc. · 2002
  7. 2 generations backK040621 Acell Ubm Surgical MeshAcell, Inc. · 2004
  8. 1 generation backK041140 Acell Ubm Surgical Mesh ML and MlplusAcell, Inc. · 2004
  9. This deviceK141084 Matristem Surgery Matrix RS, PSM, PSMX, Matristem Pelvic Floor MatrixAcell, Inc. · 2015
  10. Descendant · cites it directly · 2 of its ownK162554 Gentrix Surgical MatrixAcell, Inc. · 2016
  11. Descendant · 2 generations on · 0 of its ownK182259 Gentrix Surgical Matrix, Gentrix Surgical Matrix HiatalAcell, Inc. · 2019
  12. Descendant · 2 generations on · 0 of its ownK170763 Gentrix Surgical Matrix Thick; Gentrix Surgical Matrix ExtendAcell, Inc. · 2017 · Recalled

Most influential descendants

Showing 3 of 3 · See all
  • K162554Gentrix Surgical MatrixAcell, Inc. · 2016 · cites it directly2descendants
  • K182259Gentrix Surgical Matrix, Gentrix Surgical Matrix HiatalAcell, Inc. · 2019 · 2 generations on0descendants
  • K170763Gentrix Surgical Matrix Thick; Gentrix Surgical Matrix ExtendAcell, Inc. · 2017 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K921895Tissue Patch, Tissue GraftBio-Vascular, Inc.1992—
−7K961810Supple Peri-Guard PericardiumBio-Vascular, Inc.1996—
−6K980431SurgisisCook Biotech, Inc.1998—
−5K992159Surgisis SlingCook Biotech, Inc.1999—
−4K001738Depuy Restore Orthobiologic Soft Tissue ImplantDePuy Orthopaedics, Inc.2000—
−3K021637Acell Ubm Lyophilized Wound DressingAcell, Inc.2002—
−2K040621Acell Ubm Surgical MeshAcell, Inc.2004—
−1K041140Acell Ubm Surgical Mesh ML and MlplusAcell, Inc.2004—
0 (this device)K141084Matristem Surgery Matrix RS, PSM, PSMX, Matristem Pelvic Floor MatrixAcell, Inc.2015—
+1K162554Gentrix Surgical MatrixAcell, Inc.2016—
+2K182259Gentrix Surgical Matrix, Gentrix Surgical Matrix HiatalAcell, Inc.2019—
+2K170763Gentrix Surgical Matrix Thick; Gentrix Surgical Matrix ExtendAcell, Inc.20172

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198310
198510
198810
199130
199210
199310
199630
199730
199850
200050
200110
200210
200410

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201610
201710
201910
FIG. 1 — Lineage of K141084, 1992–2019Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FTM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FTM device

  1. #1 K262406 EluPro Antibiotic-Eluting BioEnvelopescore 15.1 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040621Acell Ubm Surgical Mesh
Summary page 4
…: Class II, 21 CFR 878.3300 Product Code: FTM, OXH Reviewing Panel: General & Plastic Surgery Predicate Devices: ACell UBM Surgical Mesh (K040621) ACell Surgical Mesh ML and ML Plus (K041140) SIS Plastic Surgery Matrix (K034039…
Acell, Inc.2004—
*K041140Acell Ubm Surgical Mesh ML and Mlplus
Summary page 4
…H Reviewing Panel: General & Plastic Surgery Predicate Devices: ACell UBM Surgical Mesh (K040621) ACell Surgical Mesh ML and ML Plus (K041140) SIS Plastic Surgery Matrix (K034039) DEVICE DESCRIPTION MatriStem® Surgical Matrix RS, PSM, PSMX, and…
Acell, Inc.2004—
*K034039Sis Plastic Surgery Matrix
Summary page 4
…Devices: ACell UBM Surgical Mesh (K040621) ACell Surgical Mesh ML and ML Plus (K041140) SIS Plastic Surgery Matrix (K034039) DEVICE DESCRIPTION MatriStem® Surgical Matrix RS, PSM, PSMX, and MatriStem ® Pelvic Floor Matrix devices are composed of porci…
Cook Biotech, Inc.2004—

Also cleared against K040621: 1 other device →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K162554Gentrix Surgical MatrixAcell, Inc.20162

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 4 companies; a new generation was cleared every 2.0 years on median.
  • 1 of the 35 ancestors has a recall of any class.
  • Of its descendants, K162554 (Acell, Inc., 2016) has gone furthest, with 2 descendants of its own.
  • 1 other device also cites its predicate K040621.

How does its category compare?

All FTM devices

FTM Mesh, Surgical: FDA decisions, review times, recalls and adverse event reports over 20 years. 2015, this device’s year, is highlighted.

FDA decisions per year · FTM

1in 2025

2007: 92008: 92009: 72010: 22011: 62012: 42013: 42014: 82015: 42016: 72017: 92018: 22019: 62020: 42021: 42023: 22024: 32025: 12026 (partial year): 1
2007high 9 (2007) · low 0 (2022)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FTM

29in 2024

2007: 104 days median2008: 86 days median2009: 86 days median2011: 100 days median2012: 66 days median2013: 123 days median2014: 153 days median2015: 316 days median2016: 88 days median2017: 147 days median2019: 107 days median2020: 59 days median2021: 61 days median2024: 29 days median
2007high 316 (2015) · low 29 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FTM

1in 2023

2007: 72008: 12010: 12011: 82018: 212019: 42020: 12021: 12023: 1
2007high 21 (2018) · low 0 (2009)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · FTM

232in 2025

2007: 602008: 1412009: 4762010: 1972011: 2882012: 4672013: 3,3512014: 1,0932015: 9772016: 5092017: 5292018: 3572019: 4182020: 4572021: 3692022: 3752023: 4852024: 3832025: 232
2007high 3,351 (2013) · low 60 (2007)2025

MAUDE reports naming product code FTM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079104760
20089861141
20097860476
20102—1197
201161008288
20124660467
2013412303,351
2014815301,093
201543160977
20167880509
201791470529
20182—21357
201961074418
20204591457
20214611369
20220—0375
20232—1485
20243290383
20251—0232
20261—0—

What is it indicated for?

MatriStem Surgical Matrix RS (2-layer) and PSM (3-layer) are intended for implantation to reinforce soft tissue where weakness exists in patients requiring urological, gastroenterological, or plastic & reconstructive surgery. Reinforcement of soft tissue within urological, gastroenterological, and plastic & reconstructive surgery includes, but is not limited to, the following procedures: hernia and body wall repair, colon and rectal prolapse repair…

Read the full statement (208 words)

MatriStem Surgical Matrix RS (2-layer) and PSM (3-layer) are intended for implantation to reinforce soft tissue where weakness exists in patients requiring urological, gastroenterological, or plastic & reconstructive surgery. Reinforcement of soft tissue within urological, gastroenterological, and plastic & reconstructive surgery includes, but is not limited to, the following procedures: hernia and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair.

MatriStem Surgical Matrix PSMX (6-layer) is intended for implantation to reinforce soft tissue where weakness exists in patients requiring gastroenterological or plastic & reconstructive surgery. Reinforcement of soft tissue within gastroenterological and plastic & reconstructive surgery includes, but is not limited to, the following procedures: hernia and body wall repair, colon and rectal prolapse repair, tissue repair, and esophageal repair.

MatriStem Pelvic Floor Matrix (6-layer) is intended for implantation to reinforce soft tissue where weakness exists in patients requiring urological or gynecological surgery. Reinforcement of soft tissue within urological and gynecological surgery includes, but is not limited to, the following procedures: pubourethral support, urethral repair, transabdominal reconstruction of pelvic floor and vaginal prolapse repair, bladder support, and sacrocolposuspension. By providing pubourethral support, MatriStem Pelvic Floor Matrix may be used for the treatment of urinary incontinence resulting from urethral hypermobility and intrinsic sphincter deficiency.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K141084: Matristem Surgery Matrix RS, PSM, PSMX, Matristem Pelvic Floor Matrix.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K141084

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026